{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:08:46Z","timestamp":1792058926502,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20203BBG73063"],"award-info":[{"award-number":["20203BBG73063"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271260"],"award-info":[{"award-number":["32271260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160335"],"award-info":[{"award-number":["82160335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360701"],"award-info":[{"award-number":["82360701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32360223"],"award-info":[{"award-number":["32360223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022957","name":"Double Thousand Plan of Jiangxi Province","doi-asserted-by":"publisher","award":["jxsq2019101064"],"award-info":[{"award-number":["jxsq2019101064"]}],"id":[{"id":"10.13039\/100022957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["xbzg-zdsys-202005"],"award-info":[{"award-number":["xbzg-zdsys-202005"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB205025"],"award-info":[{"award-number":["20232BAB205025"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212ACB216001"],"award-info":[{"award-number":["20212ACB216001"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224BAB216004"],"award-info":[{"award-number":["20224BAB216004"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224ACB206046"],"award-info":[{"award-number":["20224ACB206046"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Structural Biology: X"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.yjsbx.2026.100148","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:10:22Z","timestamp":1779981022000},"page":"100148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Inhibitory effects and structural analysis of drug candidate PF-07817883 against coronaviral main proteases (Mpro) and SARS-CoV-2 Mpro mutants"],"prefix":"10.1016","volume":"13","author":[{"given":"Zhenyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yjsbx.2026.100148_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"12","key":"10.1016\/j.yjsbx.2026.100148_bb0010","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1111\/ene.16017","article-title":"Neurological side effects and drug interactions of antiviral compounds against SARS-CoV-2","volume":"30","author":"Akhvlediani","year":"2023","journal-title":"Eur. J. Neurol."},{"issue":"16","key":"10.1016\/j.yjsbx.2026.100148_bb0015","doi-asserted-by":"crossref","first-page":"13550","DOI":"10.1021\/acs.jmedchem.3c02469","article-title":"A second-generation Oral SARS-CoV-2 main protease inhibitor clinical candidate for the treatment of COVID-19","volume":"67","author":"Allerton","year":"2024","journal-title":"J. Med. Chem."},{"issue":"5626","key":"10.1016\/j.yjsbx.2026.100148_bb0020","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0025","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"1","key":"10.1016\/j.yjsbx.2026.100148_bb0030","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1038\/s41467-021-26239-2","article-title":"Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19","volume":"12","author":"Boras","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.yjsbx.2026.100148_bb0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3390\/e16010138","article-title":"Time integrators for molecular dynamics","volume":"16","author":"Bou-Rabee","year":"2014","journal-title":"Entropy"},{"issue":"2\u20132","key":"10.1016\/j.yjsbx.2026.100148_bb0040","article-title":"Steepest-descent algorithm for simulating plasma-wave caustics via metaplectic geometrical optics","volume":"104","author":"Donnelly","year":"2021","journal-title":"Phys. Rev. E"},{"issue":"6557","key":"10.1016\/j.yjsbx.2026.100148_bb0045","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1126\/science.abg5827","article-title":"Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2","volume":"373","author":"Drayman","year":"2021","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.yjsbx.2026.100148_bb0050","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-micro-110520-023212","article-title":"Similarities and dissimilarities of COVID-19 and other coronavirus diseases","volume":"75","author":"Fung","year":"2021","journal-title":"Ann. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.yjsbx.2026.100148_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"issue":"Pt 3","key":"10.1016\/j.yjsbx.2026.100148_bb0065","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","article-title":"Conservation of substrate specificities among coronavirus main proteases","volume":"83","author":"Hegyi","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"12","key":"10.1016\/j.yjsbx.2026.100148_bb0070","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0075","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1021\/acscentsci.3c00538","article-title":"Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir","volume":"9","author":"Hu","year":"2023","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-023-01392-w","article-title":"A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7811","key":"10.1016\/j.yjsbx.2026.100148_bb0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.yjsbx.2026.100148_bb0090","doi-asserted-by":"crossref","first-page":"e02815","DOI":"10.1128\/mbio.02815-22","article-title":"The substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor in vitro and confer resistance to nirmatrelvir","volume":"14","author":"Jochmans","year":"2023","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.yjsbx.2026.100148_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2282","article-title":"An overview on the seven pathogenic human coronaviruses","volume":"32","author":"Kesheh","year":"2022","journal-title":"Rev. Med. Virol."},{"issue":"4","key":"10.1016\/j.yjsbx.2026.100148_bb0100","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1021\/acs.jmedchem.1c00509","article-title":"Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors","volume":"65","author":"Kitamura","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0105","doi-asserted-by":"crossref","unstructured":"Lamb YN. BNT162b2 mRNA COVID-19 vaccine: first approval. Drugs 20211;81(4):495\u2013501.","DOI":"10.1007\/s40265-021-01480-7"},{"issue":"7","key":"10.1016\/j.yjsbx.2026.100148_bb0110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.scib.2020.10.018","article-title":"Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode","volume":"66","author":"Li","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"issue":"1","key":"10.1016\/j.yjsbx.2026.100148_bb0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02013-21","article-title":"Structural basis of the main proteases of coronavirus bound to drug candidate PF-07321332","volume":"96","author":"Li","year":"2022","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114520","article-title":"Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants","volume":"43","author":"Li","year":"2024","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0130","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/prot.22711","article-title":"Improved side-chain torsion potentials for the Amber ff99SB protein force field","volume":"78","author":"Lindorff-Larsen","year":"2010","journal-title":"Proteins"},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0135","article-title":"The rising SARS-CoV-2 JN.1 variant: evolution, infectivity, immune escape, and response strategies","volume":"5","author":"Lu","year":"2024","journal-title":"Med. Comm (2020)."},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0140","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.yjsbx.2026.100148_bb0145","article-title":"Structural basis of potential inhibitors targeting SARS-CoV-2 main protease","volume":"12","author":"Mengist","year":"2021","journal-title":"Front. Chem."},{"issue":"10","key":"10.1016\/j.yjsbx.2026.100148_bb0150","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1021\/ct2002732","article-title":"Comparison of tetrahedral order, liquid state anomalies, and hydration behavior of mTIP3P and TIP4P water models","volume":"7","author":"Nayar","year":"2011","journal-title":"J. Chem. Theory Comput."},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011592","article-title":"A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations","volume":"19","author":"Ou","year":"2023","journal-title":"PLoS Pathog."},{"issue":"6575","key":"10.1016\/j.yjsbx.2026.100148_bb0160","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.yjsbx.2026.100148_bb0165","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00894-010-0650-7","article-title":"An improved generalized AMBER force field (GAFF) for urea[J\/OL]","volume":"16","author":"\u00d6zpinar","year":"2010","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0170","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2022.09.010","article-title":"Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: design, identification, and correlation with globally circulating viral genomes","volume":"629","author":"Padhi","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.yjsbx.2026.100148_bb0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s13238-013-2841-3","article-title":"The newly emerged SARS-like coronavirus HCoV-EMC also has an \u201cAchilles\u2019 heel\u201d: current effective inhibitor targeting a 3C-like protease","volume":"4","author":"Ren","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.yjsbx.2026.100148_bb0180","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1038\/s41467-022-31210-w","article-title":"Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance","volume":"13","author":"Shaqra","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.yjsbx.2026.100148_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105246","article-title":"Human coronaviruses: origin, host and receptor","volume":"155","author":"Tang","year":"2022","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128629","article-title":"Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir","volume":"62","author":"Ullrich","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.yjsbx.2026.100148_bb0205","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theory Comput."},{"issue":"16","key":"10.1016\/j.yjsbx.2026.100148_bb0210","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0215","first-page":"775","article-title":"Pharmacokinetic enhancers for HIV drugs","volume":"10","author":"Xu","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"6489","key":"10.1016\/j.yjsbx.2026.100148_bb0220","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.yjsbx.2026.100148_bb0225","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01253-21","article-title":"Structure-based discovery and structural basis of a novel broad-spectrum natural product against the main protease of coronavirus","volume":"96","author":"Zhang","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.yjsbx.2026.100148_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add7197","article-title":"Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system","volume":"8","author":"Zhou","year":"2022","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.yjsbx.2026.100148_bb0235","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Structural Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590152426000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590152426000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:15:57Z","timestamp":1783106157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590152426000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S2590152426000061"],"URL":"https:\/\/doi.org\/10.1016\/j.yjsbx.2026.100148","relation":{},"ISSN":["2590-1524"],"issn-type":[{"value":"2590-1524","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects and structural analysis of drug candidate PF-07817883 against coronaviral main proteases (Mpro) and SARS-CoV-2 Mpro mutants","name":"articletitle","label":"Article Title"},{"value":"Journal of Structural Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjsbx.2026.100148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100148"}}